Highlights
NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
122.295   -0.695 (0.57%)  118.26 - 135.23  37,910

Overview

 
Avg Volume (4 weeks):240,788
4 Weeks Range:105.90 - 139.86
4 Weeks Price Volatility (%):
48.28%
52 Weeks Range:91.56 - 325.98
52 Weeks Price Volatility (%):
13.11%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.
 


 

2878  4306  813  722 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 P 8.38-0.11 
 HMNY 0.007-0.001 
 ENLK 12.05-0.47 
 AHL 42.74+0.23 
 VIPS 6.335-0.975 
 IMDZ 5.81+4.39 
 AMD 24.07+0.12 
 ORBK 65.770.00 
 VXX 38.69-0.15 
 SPY 277.305-1.105 
Partners & Brokers